Antonio Juretić

1.9k total citations
69 papers, 1.4k citations indexed

About

Antonio Juretić is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Antonio Juretić has authored 69 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 21 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Antonio Juretić's work include Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (16 papers) and T-cell and B-cell Immunology (13 papers). Antonio Juretić is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (16 papers) and T-cell and B-cell Immunology (13 papers). Antonio Juretić collaborates with scholars based in Croatia, Switzerland and Italy. Antonio Juretić's co-authors include Giulio C. Spagnoli, Jan Klein, Zoltán Á. Nagy, Constantin N. Baxevanis, Michael Heberer, Elke Schultz‐Thater, F. Harder, Božena Šarčević, Luis Filgueira and Christoph Schaefer and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Antonio Juretić

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Juretić Croatia 21 975 570 339 207 127 69 1.4k
Silke Meister Germany 16 889 0.9× 630 1.1× 231 0.7× 162 0.8× 88 0.7× 26 1.8k
Theodora W. Salcedo United States 18 931 1.0× 403 0.7× 495 1.5× 237 1.1× 74 0.6× 30 1.5k
Xiao‐Jie Yan United States 28 1.6k 1.6× 583 1.0× 387 1.1× 241 1.2× 47 0.4× 93 2.6k
Yoichi Tatsumi Japan 22 550 0.6× 255 0.4× 342 1.0× 156 0.8× 58 0.5× 74 1.2k
Tobias A.W. Holderried Germany 19 1.2k 1.2× 629 1.1× 549 1.6× 70 0.3× 143 1.1× 58 1.9k
Xiaoyan Qiu China 20 525 0.5× 551 1.0× 234 0.7× 335 1.6× 54 0.4× 37 1.1k
Ann‐Christine Syvänen Sweden 15 882 0.9× 404 0.7× 329 1.0× 142 0.7× 99 0.8× 22 1.6k
Olivier Spertini Switzerland 15 675 0.7× 378 0.7× 205 0.6× 83 0.4× 71 0.6× 51 1.4k
Kazuhiro Hayashida Japan 17 725 0.7× 367 0.6× 336 1.0× 119 0.6× 79 0.6× 44 1.4k
Susan J. Faas United States 23 1.2k 1.2× 657 1.2× 245 0.7× 143 0.7× 105 0.8× 37 1.9k

Countries citing papers authored by Antonio Juretić

Since Specialization
Citations

This map shows the geographic impact of Antonio Juretić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Juretić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Juretić more than expected).

Fields of papers citing papers by Antonio Juretić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Juretić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Juretić. The network helps show where Antonio Juretić may publish in the future.

Co-authorship network of co-authors of Antonio Juretić

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Juretić. A scholar is included among the top collaborators of Antonio Juretić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Juretić. Antonio Juretić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vrdoljak, Eduard, Stjepko Pleština, Antonio Juretić, et al.. (2018). CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING PATIENTS WITH COLORECTAL CANCER. University of Zagreb University Computing Centre (SRCE). 140(9-10). 241–247. 4 indexed citations
2.
Juretić, Antonio. (2017). Cancer immunotherapy: mechanism of action. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 45. 38–42. 1 indexed citations
3.
Prusac, Ivana Kuzmiç, et al.. (2017). MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer. International Journal of Gynecological Pathology. 38(1). 59–65. 5 indexed citations
4.
Juretić, Antonio. (2017). Prostate cancer immunotherapy. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 45. 69–71. 1 indexed citations
5.
Juretić, Antonio. (2014). Recent advances in clinical anti-cancer immunotherapy. Periodicum Biologorum. 116(4). 365–370. 1 indexed citations
6.
Mrklić, Ivana, Giulio C. Spagnoli, Antonio Juretić, Zenon Pogorelić, & Snježana Tomić. (2014). Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas. Acta Histochemica. 116(5). 740–746. 9 indexed citations
7.
8.
Gamulin, Marija, et al.. (2010). DNA and cytogenetic damage in white blood cells of postmenopausal breast cancer patients treated with radiotherapy. Journal of Environmental Science and Health Part A. 45(3). 292–304. 7 indexed citations
9.
Juretić, Antonio, et al.. (2006). Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.. PubMed. 47(1). 32–41. 45 indexed citations
10.
Hudolin, Tvrtko, Antonio Juretić, Josip Pasini, et al.. (2006). Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis. Urology. 68(1). 205–207. 9 indexed citations
11.
12.
Užarević, Branka, et al.. (2000). Two-Color Flow Cytometric Analysis of Preterm and Term Newborn Lymphocytes. Immunobiology. 202(5). 421–428. 29 indexed citations
13.
Juretić, Antonio, et al.. (1996). Expression of MAGE-1, -2 and -3 genes in primary and metastatic lesions of human malignant melanomas. Croatian Medical Journal. 37(2). 119–122. 2 indexed citations
14.
Falcioni, Fiorenza, et al.. (1996). Induction of class II major histocompatibility complex blockade as well as T cell tolerance by peptides administered in soluble form. European Journal of Immunology. 26(8). 1736–1742. 2 indexed citations
15.
Spagnoli, Giulio C., Christoph Schaefer, Thomas Köcher, et al.. (1995). Peptide‐specific ctl in tumor‐infiltrating lymphocytes from metastatic melanomas expressing mart‐1/melan‐a, gp100 and tyrosinase genes: A study in an unselected group of hla‐a2.1‐positive patients. International Journal of Cancer. 64(5). 309–315. 44 indexed citations
16.
17.
Schultz‐Thater, Elke, Antonio Juretić, Paolo Dellabona, et al.. (1994). MAGE‐1 gene product is a cytoplasmic protein. International Journal of Cancer. 59(3). 435–439. 53 indexed citations
18.
Hörig, Heidi, Giulio C. Spagnoli, Luis Filgueira, et al.. (1993). Exogenous glutamine requirement is confined to late events of T cell activation. Journal of Cellular Biochemistry. 53(4). 343–351. 67 indexed citations
19.
Merlo, Adrian, Antonio Juretić, Luis Filgueira, et al.. (1993). Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. European Journal of Cancer. 29(15). 2118–2125. 40 indexed citations
20.
Juretić, Antonio & Barbara B. Knowles. (1989). SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice. Immunogenetics. 29(6). 366–370. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silke Meister Breakdown of academic impact, for papers by Theodora W. Salcedo Breakdown of academic impact, for papers by Xiao‐Jie Yan Breakdown of academic impact, for papers by Yoichi Tatsumi Breakdown of academic impact, for papers by Tobias A.W. Holderried Breakdown of academic impact, for papers by Xiaoyan Qiu Breakdown of academic impact, for papers by Ann‐Christine Syvänen Breakdown of academic impact, for papers by Olivier Spertini Breakdown of academic impact, for papers by Kazuhiro Hayashida Breakdown of academic impact, for papers by Susan J. Faas
Rankless by CCL
2026